Network pharmacology to explore the mechanism of scutellarin in the treatment of brain ischaemia and experimental verification of JAK2/STAT3 signalling pathway

Scutellarin is used to treat brain ischaemia. However, its underlying mechanism of action remains unclear. This study aimed to elucidate the potential mechanism of action of scutellarin in brain ischaemia through network pharmacology and experimental verification. The JAK2/STAT3 signalling pathway w...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Qiu-Ye, Chen, Hao‑Lun, Qi, Zhi, Zhang, Xiao‑Li‑Na, Zheng, Li-Yang, Liu, Teng-Teng, Yuan, Yun, Yang, Li, Wu, Chun‑Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169761/
https://www.ncbi.nlm.nih.gov/pubmed/37160937
http://dx.doi.org/10.1038/s41598-023-33156-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169761/
https://www.ncbi.nlm.nih.gov/pubmed/37160937
http://dx.doi.org/10.1038/s41598-023-33156-5

Ejemplares similares